Home/Filings/4/0000950170-24-135983
4//SEC Filing

STEPHENSON BRIAN C 4

Accession 0000950170-24-135983

CIK 0001743881other

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 7:00 PM ET

Size

5.6 KB

Accession

0000950170-24-135983

Insider Transaction Report

Form 4
Period: 2024-12-10
STEPHENSON BRIAN C
Secretary, Treasurer & CFO
Transactions
  • Award

    Restricted Stock Units

    2024-12-10+42,68342,683 total
    Common Stock (42,683 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F2]The RSUs vest with respect to 1/2 of the underlying shares on December 12, 2025. Thereafter, the remaining underlying shares shall vest on December 12, 2026, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

Documents

1 file

Issuer

BridgeBio Pharma, Inc.

CIK 0001743881

Entity typeother

Related Parties

1
  • filerCIK 0001780030

Filing Metadata

Form type
4
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 7:00 PM ET
Size
5.6 KB